These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35074241)

  • 1. Imaging characteristics of hypertrophic pachymeningitis due to ANCA-associated vasculitis.
    Takagi T; Okada M; Nakamura M; Hanari T; Nakata T; Teraoka M; Hato N
    Auris Nasus Larynx; 2022 Oct; 49(5):875-879. PubMed ID: 35074241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and treatment outcomes of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV): A retrospective analysis of 235 patients from a nationwide survey in Japan.
    Harabuchi Y; Kishibe K; Tateyama K; Morita Y; Yoshida N; Kunimoto Y; Matsui T; Sakaguchi H; Okada M; Watanabe T; Inagaki A; Kobayashi S; Iino Y; Murakami S; Takahashi H; Tono T
    Mod Rheumatol; 2017 Jan; 27(1):87-94. PubMed ID: 27166750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between ear involvement and clinical features and prognosis in ANCA-associated vasculitis.
    Hosokawa Y; Okada M; Suemori K; Hamaguchi N; Miyoshi KI; Takagi T; Teraoka M; Yamada H; Ishizaki J; Matsumoto T; Hato N
    Auris Nasus Larynx; 2021 Oct; 48(5):885-889. PubMed ID: 33589280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertrophic pachymeningitis in ANCA-associated vasculitis: Clinical and immunopathological features and insights.
    Shimojima Y; Sekijima Y
    Autoimmun Rev; 2023 Jun; 22(6):103338. PubMed ID: 37062439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics, the diagnostic criteria and management recommendation of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) proposed by Japan Otological Society.
    Harabuchi Y; Kishibe K; Tateyama K; Morita Y; Yoshida N; Okada M; Kunimoto Y; Watanabe T; Inagaki A; Yoshida T; Imaizumi M; Nakamura T; Matsunobu T; Kobayashi S; Iino Y; Murakami S; Takahashi H; Tono T
    Auris Nasus Larynx; 2021 Feb; 48(1):2-14. PubMed ID: 32768313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical analysis of 15 cases with myeloperoxidase antineutrophil cytoplasmic antibody associated hypertrophic pachymeningitis].
    Guan WJ; Ding YX; Liu LJ; Li W; Jing LJ; Zhang X; Zhang LJ; Li H; Cheng SH; Liu SY
    Zhonghua Nei Ke Za Zhi; 2022 May; 61(5):565-569. PubMed ID: 35488609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locations and Predictive Factors of Hypertrophic Pachymeningitis in Otitis Media With Antineutrophil Cytoplasmic Antigen-Associated Vasculitis.
    Morita Y; Kitazawa M; Yagi C; Takahashi K; Ohshima S; Yamagishi T; Izumi S; Horii A
    Otol Neurotol; 2022 Sep; 43(8):e835-e840. PubMed ID: 35960882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-neutrophil cytoplasmic antibody-associated hypertrophic cranial pachymeningitis and otitis media: a review of literature.
    Peng A; Yang X; Wu W; Xiao Z; Xie D; Ge S
    Eur Arch Otorhinolaryngol; 2018 Dec; 275(12):2915-2923. PubMed ID: 30328500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertrophic pachymeningitis in ANCA-associated vasculitis: a cross-sectional and multi-institutional study in Japan (J-CANVAS).
    Shimojima Y; Kishida D; Ichikawa T; Kida T; Yajima N; Omura S; Nakagomi D; Abe Y; Kadoya M; Takizawa N; Nomura A; Kukida Y; Kondo N; Yamano Y; Yanagida T; Endo K; Hirata S; Matsui K; Takeuchi T; Ichinose K; Kato M; Yanai R; Matsuo Y; Nishioka R; Okazaki R; Takata T; Ito T; Moriyama M; Takatani A; Miyawaki Y; Ito-Ihara T; Kawaguchi T; Kawahito Y; Sekijima Y
    Arthritis Res Ther; 2022 Aug; 24(1):204. PubMed ID: 35999568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertrophic pachymeningitis associated with antineutrophil cytoplasmic antibody-associated vasculitis: a case series of 15 patients.
    Sakairi T; Sakurai N; Nakasatomi M; Ikeuchi H; Kaneko Y; Maeshima A; Nojima Y; Hiromura K
    Scand J Rheumatol; 2019 May; 48(3):218-224. PubMed ID: 30394816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of and Prognosis for Facial Palsy in Patients With Otitis Media With ANCA-Associated Vasculitis (OMAAV).
    Fujiwara K; Morita S; Fukuda A; Yanagi H; Hoshino K; Nakamaru Y; Furuta Y; Homma A
    Otol Neurotol; 2021 Dec; 42(10):e1577-e1582. PubMed ID: 34353982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Localized and Systemic Otitis Media With ANCA-Associated Vasculitis.
    Okada M; Suemori K; Takagi D; Teraoka M; Yamada H; Hato N
    Otol Neurotol; 2017 Dec; 38(10):e506-e510. PubMed ID: 28885482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertrophic pachymeningitis is a characteristic manifestation of granulomatosis with polyangiitis: A retrospective study of anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Shimojima Y; Kishida D; Hineno A; Yazaki M; Sekijima Y; Ikeda SI
    Int J Rheum Dis; 2017 Apr; 20(4):489-496. PubMed ID: 28217942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertrophic spinal pachymeningitis caused by ANCA-associated vasculitis revealed by 18F-FDG PET/CT: A case report.
    Wu M; Ren J; Luo Y
    Medicine (Baltimore); 2021 Jan; 100(3):e24388. PubMed ID: 33546079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Complicated by Periaortitis and Cranial Hypertrophic Pachymeningitis: A Report of an Autopsy Case.
    Kaga H; Komatsuda A; Saito M; Nara M; Omokawa A; Togashi M; Okuyama S; Wakui H; Takahashi N
    Intern Med; 2018 Jan; 57(1):107-113. PubMed ID: 29021484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intractable otitis media - Pathogenesis and treatment of Eosinophilic otitis media (EOM) and otitis media with Antineutrophil cytoplasmic antibody (ANCA) -associated vasculitis (OMAAV).
    Yoshida N
    Auris Nasus Larynx; 2023 Apr; 50(2):171-179. PubMed ID: 35934599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis and diagnosis of otitis media with ANCA-associated vasculitis.
    Yoshida N; Iino Y
    Allergol Int; 2014 Dec; 63(4):523-32. PubMed ID: 25339433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody.
    Yokoseki A; Saji E; Arakawa M; Kosaka T; Hokari M; Toyoshima Y; Okamoto K; Takeda S; Sanpei K; Kikuchi H; Hirohata S; Akazawa K; Kakita A; Takahashi H; Nishizawa M; Kawachi I
    Brain; 2014 Feb; 137(Pt 2):520-36. PubMed ID: 24271323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Otitis media with ANCA-associated vasculitis: A retrospective study of 30 patients.
    Tabei A; Sakairi T; Ohishi Y; Watanabe M; Nakasatomi M; Hamatani H; Ikeuchi H; Kaneko Y; Hiromura K
    Mod Rheumatol; 2022 Aug; 32(5):923-929. PubMed ID: 34915561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tympanic membrane findings of otitis media with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV).
    Morita Y; Kitazawa M; Yagi C; Nonomura Y; Takahashi K; Yamagishi T; Ohshima S; Izumi S; Horii A
    Auris Nasus Larynx; 2020 Oct; 47(5):740-746. PubMed ID: 32173171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.